预防界.A-A+根除幽门螺杆菌感染,FDA批准创新组合疗法 参考资料:[1] Phathom Pharmaceuticals Announces FDA Approval of VOQUEZNA™ TRIPLE PAK™ (vonoprazan, amoxicillin, clarithromycin) and VOQUEZNA™ DUAL PAK™ (vonoprazan, amoxicillin) for the Treatment of H. pylori Infection in Adults. Retrieved May 3, 2022, from https://www.globenewswire.com/news-release/2022/05/03/2435147/0/en/Phathom-Pharmaceuticals-Announces-FDA-Approval-of-VOQUEZNA-TRIPLE-PAK-vonoprazan-amoxicillin-clarithromycin-and-VOQUEZNA-DUAL-PAK-vonoprazan-amoxicillin-for-the-Treatment-of-H-pylo.html来源:药明康德
(责任编辑:dawenwu)
疫苗前沿 | 根除幽门螺杆菌感染,FDA批准创新组合疗法
389